Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, Other), By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR875DR | Pages: 160

Market Segmentation

  1. Antibiotics Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Cephalosporin
    2. Penicillin
    3. Fluoroquinolone
    4. Macrolides
    5. Carbapenem
    6. Aminoglycosides
    7. Sulfonamides
    8. Other
  2. Antibiotics Market, By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
    1. Broad-spectrum Antibiotic
    2. Narrow-spectrum Antibiotic
  3. Regional Antibiotics Market
    1. North America
      1. North America Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. North America Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. U.S. Antibiotics Market
        1. U.S. Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. U.S. Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      4. Canada Antibiotics Market
        1. Canada Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Canada Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
    2. Europe
      1. Europe Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. Europe Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. U.K. Antibiotics Market
        1. U.K. Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. U.K. Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      4. Germany Antibiotics Market
        1. Germany Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Germany Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      5. France Antibiotics Market
        1. France Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. France Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      6. Spain Antibiotics Market
        1. Spain Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Spain Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      7. Italy Antibiotics Market
        1. Italy Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Italy Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      8. Russia Antibiotics Market
        1. Russia Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Russia Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      9. Nordic Antibiotics Market
        1. Nordic Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Nordic Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      10. Benelux Antibiotics Market
        1. Benelux Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Benelux Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      11. Rest of Europe Antibiotics Market
        1. Rest of Europe Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Rest of Europe Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
    3. APAC
      1. APAC Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. APAC Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. China Antibiotics Market
        1. China Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. China Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      4. Korea Antibiotics Market
        1. Korea Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Korea Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      5. Japan Antibiotics Market
        1. Japan Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Japan Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      6. India Antibiotics Market
        1. India Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. India Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      7. Australia Antibiotics Market
        1. Australia Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Australia Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      8. Taiwan Antibiotics Market
        1. Taiwan Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Taiwan Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      9. South East Asia Antibiotics Market
        1. South East Asia Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. South East Asia Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      10. Rest of Asia-Pacific Antibiotics Market
        1. Rest of Asia-Pacific Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Rest of Asia-Pacific Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
    4. Middle East and Africa
      1. Middle East and Africa Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. Middle East and Africa Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. UAE Antibiotics Market
        1. UAE Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. UAE Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      4. Turkey Antibiotics Market
        1. Turkey Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Turkey Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      5. Saudi Arabia Antibiotics Market
        1. Saudi Arabia Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Saudi Arabia Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      6. South Africa Antibiotics Market
        1. South Africa Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. South Africa Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      7. Egypt Antibiotics Market
        1. Egypt Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Egypt Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      8. Nigeria Antibiotics Market
        1. Nigeria Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Nigeria Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      9. Rest of MEA Antibiotics Market
        1. Rest of MEA Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Rest of MEA Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
    5. LATAM
      1. LATAM Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. LATAM Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. Brazil Antibiotics Market
        1. Brazil Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Brazil Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      4. Mexico Antibiotics Market
        1. Mexico Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Mexico Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      5. Argentina Antibiotics Market
        1. Argentina Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Argentina Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      6. Chile Antibiotics Market
        1. Chile Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Chile Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      7. Colombia Antibiotics Market
        1. Colombia Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Colombia Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
      8. Rest of LATAM Antibiotics Market
        1. Rest of LATAM Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Cephalosporin
          2. Penicillin
          3. Fluoroquinolone
          4. Macrolides
          5. Carbapenem
          6. Aminoglycosides
          7. Sulfonamides
          8. Other
        2. Rest of LATAM Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
          1. Broad-spectrum Antibiotic
          2. Narrow-spectrum Antibiotic
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: